Ollin Biosciences

Ollin Biosciences™, founded in 2023, is a clinical-stage biopharmaceutical company dedicated to acquiring and developing the best disease therapies for vision-threatening conditions. With a differentiated pipeline, a world-class team, and a strong consortium of investors, Ollin is redefining the possibilities in ophthalmology.